Reported 2 days ago
Zimmer Biomet Holdings (ZBH) experienced a downturn in its stock value after the company lowered its financial guidance due to dilution from an acquisition and an expected impact from pending tariffs. Despite a solid earnings report and a 7% increase in net sales, the company lost market share in knee replacement products. Analysts view this reduction in guidance as a temporary setback and anticipate revenue growth will recover with an upcoming release cycle.
Source: YAHOO